Sessions/Tracks

Cervical cancer remains one of the most preventable yet challenging diseases in women’s health. This track focuses on innovative screening tools, HPV vaccination strategies, and global elimination roadmaps endorsed by WHO. Experts will discuss the integration of molecular testing, self-sampling methods, and AI-driven cytology into clinical practice. With emphasis on early detection, cost-effectiveness, and access in low-resource settings, the sessions aim to bridge disparities in cervical cancer prevention. The discussions will highlight how collaborative initiatives and policy frameworks can accelerate progress toward the global elimination target.

• HPV vaccination programs and global elimination strategies
• AI, biomarkers, and next-gen screening technologies
• Policy frameworks and implementation in low-resource settings

Artificial intelligence and robotics are revolutionizing gynecological and reproductive care. This track will explore how machine learning algorithms, robotic-assisted surgeries, and decision-support systems are improving patient outcomes. Sessions will include discussions on reproductive endocrinology, embryo selection in IVF, and AI-based risk prediction for gynecologic conditions. Experts will also highlight ethical considerations, cost implications, and training needs for adopting these technologies. Delegates will gain insights into how AI and robotics are moving from theory to practical, evidence-based applications in clinical practice.

• Robotic-assisted gynecologic surgery and innovations in training
• AI in IVF: embryo selection, outcome prediction, and personalization
• Ethical, legal, and cost-effectiveness issues in AI adoption

Fertility preservation is increasingly vital for women facing cancer treatments, genetic disorders, or delayed parenthood. This track will highlight advances in cryopreservation, ovarian tissue banking, and cutting-edge IVF technologies. Experts will discuss improvements in stimulation protocols, lab techniques, and personalized embryo transfer strategies. The sessions will also focus on inclusivity, addressing fertility options for patients with chronic illness and LGBTQ+ communities. With rapid innovations, fertility preservation is becoming a central pillar of reproductive healthcare.

• Advances in cryopreservation and ovarian tissue transplantation
• Personalized IVF: novel protocols, biomarkers, and lab techniques
• Fertility preservation for oncology patients and diverse populations

Non-invasive treatments are transforming care pathways for uterine fibroids and endometriosis, conditions that affect millions worldwide. This track will review pharmacological therapies, hormonal modulators, and minimally invasive procedures such as focused ultrasound. Attention will be given to patient-reported outcomes, fertility preservation, and long-term management strategies. Delegates will learn how personalized treatment approaches are shifting away from radical surgery. Multidisciplinary care models will also be explored, linking gynecology with pain management, endocrinology, and mental health.

• Medical therapies: hormonal, non-hormonal, and novel drug approaches
• Minimally invasive options: embolization, HIFU, and emerging techniques
• Patient-centered care and long-term management strategies

Digital health solutions are reshaping the way women access and experience healthcare. This track will spotlight telemedicine platforms, wearable devices, and FemTech innovations designed to monitor reproductive health, fertility, and chronic conditions. Case studies will showcase how mobile apps, AI chatbots, and remote monitoring tools are improving access in underserved regions. Discussions will also address data privacy, digital literacy, and regulatory challenges. Delegates will learn how digital health bridges gaps in care delivery and enhances patient empowerment.

• FemTech innovations in reproductive and maternal health
• Telemedicine models for gynecology and women’s health
• Data security, privacy, and ethical considerations in digital health

Precision medicine is redefining gynecological care by tailoring treatments to genetic, molecular, and lifestyle factors. This track will highlight the integration of genomics, proteomics, and AI-based analytics in managing gynecologic disorders. From tailoring hormone therapy to designing individualized cancer care pathways, precision approaches are transforming outcomes. Experts will discuss how personalized screening and treatment enhance effectiveness while minimizing side effects. Delegates will explore both current practices and future directions in precision gynecology.

• Genetic and molecular profiling in gynecologic disorders
• Precision oncology: individualized treatment strategies
• Pharmacogenomics and tailoring hormone or fertility treatments

Rapid advances in genomics and molecular biology are unraveling the complex mechanisms underlying gynecological diseases. This track will explore genetic predispositions, epigenetics, and biomarker discovery for conditions like PCOS, endometriosis, and gynecologic cancers. Presentations will focus on translational research, moving laboratory findings into clinical applications. The role of next-generation sequencing and molecular diagnostics in early detection will also be emphasized. By bridging science and clinical care, this track underscores the promise of precision therapies in gynecology.

• Genetic and epigenetic mechanisms in gynecologic diseases
• Molecular biomarkers for early diagnosis and prognosis
• Translational genomics: bridging lab research and clinical practice

Immunotherapy and targeted treatments are revolutionizing the management of gynecologic malignancies. This track will highlight breakthroughs in checkpoint inhibitors, CAR-T therapy, and PARP inhibitors for ovarian and endometrial cancers. Case studies will showcase clinical trial results and real-world applications. Delegates will gain insights into resistance mechanisms, combination strategies, and biomarkers that predict therapy response. The sessions will also examine regulatory approvals and cost-effectiveness in implementing these therapies globally.

• Immunotherapy: checkpoint inhibitors, CAR-T, and vaccine strategies
• Targeted therapies in ovarian and endometrial cancers
• Overcoming resistance and optimizing combination treatments

Polycystic Ovary Syndrome (PCOS) is a multifaceted condition impacting metabolic, endocrine, and reproductive health. This track will explore the latest research on PCOS pathophysiology, clinical management, and long-term health risks such as diabetes and cardiovascular disease. Emphasis will be placed on individualized treatment approaches, including lifestyle interventions, pharmacological therapies, and fertility management. The psychosocial and mental health impact of PCOS will also be discussed. Delegates will gain a comprehensive understanding of PCOS across the lifespan.

• Endocrine and metabolic pathways of PCOS
• Fertility management and reproductive outcomes
• Mental health, lifestyle, and holistic care approaches

Minimally invasive approaches have transformed gynecologic surgery, offering patients faster recovery, less pain, and improved outcomes. This track will explore innovations in laparoscopic, hysteroscopic, and robotic-assisted procedures for common gynecological conditions. Presentations will cover advanced training methods, simulation-based education, and enhanced surgical precision with AI-guided tools. Delegates will also discuss patient safety, surgical outcomes, and the expansion of minimally invasive surgery in resource-limited settings. This track is designed to inspire innovation while ensuring accessibility and quality of care.

• Advances in laparoscopic and hysteroscopic procedures
• Robotic-assisted surgery and AI-guided surgical tools
• Training, simulation, and global accessibility challenges

Maternal mortality remains a pressing global challenge despite advances in healthcare. This track focuses on innovative strategies to reduce maternal deaths and improve prenatal care models. Sessions will highlight multidisciplinary approaches, including digital monitoring, risk stratification, and policy reforms. Case studies from both high- and low-resource countries will provide insights into successful interventions. Delegates will explore how redesigning prenatal systems can bridge gaps in equity and ensure safer pregnancies worldwide.

• Innovations in prenatal monitoring and risk prediction
• Community-based interventions and policy strategies
• Addressing inequities in maternal health across regions

Postpartum health is an often-overlooked dimension of women’s care, with profound effects on long-term well-being. This track will explore recovery strategies, pelvic floor health, and sexual wellness after childbirth. Experts will share insights into physical rehabilitation, psychological support, and integrative care models. Discussions will also highlight new technologies in postpartum monitoring and interventions to improve quality of life. Delegates will gain a deeper understanding of how holistic postpartum care supports both maternal and family health.

• Pelvic floor rehabilitation and innovations in postpartum care
• Sexual health, intimacy, and mental wellness after childbirth
• Digital health and monitoring tools for postpartum recovery

Environmental exposures play a significant role in reproductive health outcomes. This track will focus on the impact of toxins, endocrine disruptors, and environmental pollutants on fertility, pregnancy, and fetal development. Case studies will highlight both occupational and lifestyle-related risks. Delegates will also learn about recent advances in toxicogenomics, risk mitigation strategies, and policy advocacy for safer environments. This track underscores the importance of environmental awareness in safeguarding reproductive health for future generations.

• Toxicogenomics and molecular insights in reproductive toxicology
• Environmental risk factors and maternal-fetal health
• Public health policies and prevention strategies

Contraceptive options are rapidly evolving to meet the diverse needs of women worldwide. This track will explore long-acting reversible contraceptives (LARCs), emerging non-hormonal methods, and personalized contraceptive counseling models. Sessions will include updates on efficacy, safety, and accessibility in various healthcare settings. Experts will also address myths, stigma, and policy challenges associated with contraception use. Delegates will leave with updated knowledge on the future of contraceptive technologies and approaches to equitable access.

• Advances in LARCs and new contraceptive technologies
• Personalized contraceptive counseling and patient engagement
• Global access, stigma, and policy barriers in contraception

Managing menstrual and hormonal disorders requires more than pharmacological interventions. This track will explore integrative strategies including lifestyle interventions, nutrition, acupuncture, and mindfulness-based therapies. Experts will present evidence on the benefits of combining conventional medicine with holistic care. Sessions will emphasize patient-centered approaches that improve quality of life and long-term outcomes. Delegates will gain insights into how integrative medicine is redefining menstrual and hormonal health.

• Lifestyle, diet, and exercise in managing menstrual disorders
• Complementary therapies: acupuncture, yoga, and mindfulness
• Integrative care models for PCOS, PMS, and menopause

Inequities in women’s healthcare access remain a global challenge, particularly in low- and middle-income countries. This track will explore strategies to ensure equitable healthcare delivery, from maternal health to cancer screening. Experts will share case studies of community-based interventions, NGO-driven initiatives, and digital solutions. Discussions will also highlight the role of policymakers and international collaborations in advancing equity. This track emphasizes a future where no woman is left behind in healthcare access.

• Barriers to women’s healthcare access in low-resource settings
• Community-driven models and NGO-led interventions
• Policy advocacy and global collaborations for equity

Gynecological disorders often have neurological and systemic implications that require multidisciplinary care. This track will examine conditions such as endometriosis-related neuropathic pain, hormonal influences on mood disorders, and systemic links between gynecology and cardiology. Experts will present the latest research on brain–hormone interactions, chronic pain management, and neuropsychiatric comorbidities. Delegates will gain a holistic understanding of how gynecologic health intersects with overall systemic well-being.

• Neuropathic pain and neuropsychiatric comorbidities in gynecology
• Hormonal influences on neurological and psychiatric health
• Interdisciplinary management of systemic manifestations

The future of OB/GYN practice is being reshaped by demographic shifts, new technologies, and evolving patient expectations. This track will explore workforce planning, training innovations, and the redesign of women’s health clinics. Sessions will cover telehealth integration, team-based care, and leadership in OB/GYN. Experts will also address strategies to reduce workforce burnout and improve diversity in the field. Delegates will engage in discussions on building a sustainable and inclusive OB/GYN workforce for the future.

• Workforce trends, training, and professional sustainability
• Innovations in clinic design and patient-centered models
• Diversity, equity, and inclusion in OB/GYN practice

Regenerative medicine and integrative approaches are opening new possibilities in women’s healthcare. This track will focus on stem cell therapy, tissue engineering, and regenerative approaches for reproductive and gynecologic conditions. Presentations will also explore integrative care models that combine regenerative therapies with lifestyle and holistic medicine. Ethical and regulatory considerations will be central to the discussions. Delegates will gain insights into how future therapies can restore function, enhance fertility, and transform women’s health care.

• Stem cell therapy and tissue engineering applications
• Integrating regenerative and holistic medicine in practice
• Ethical, legal, and clinical translation challenges